Shares of Park Medi World Ltd. fell sharply by nearly 8% on Friday, November 13, after the company reported a weak set of earnings for the second quarter. Barring its revenue, Park Medi World's earnings declined across the other key parameters on a year-on-year basis.
For the September quarter, Park Medi World's revenue of ₹511 crore grew by 24.6% from ₹410 crore it reported during the second quarter last year. Net profit fell 29.7% to ₹52 crore in the September quarter from ₹74 crore during the year-ago quarter. Earnings before interest, taxes, depreciation and amortization declined by 9.5% during the quarter to ₹101.8 crore from ₹112.5 crore in the corresponding quarter in the previous fiscal.
The company's EBITDA margin contracted sharply by 740 basis points to 20% from 27.4% in the year-ago period. Shares of Park Medi World 7.7% to hit an intraday low of ₹236.01 apiece. The stock is up 1% in the past month, has declined 4% in the last six months but has gained 58.3% in 2026, so far.
The stock, which is listed at a 4% discount on the exchanges in December 2025, is up 46% from its issue price of ₹162 per share and up 50% from its listing price of ₹158.8 apiece. Nomura highlights key triggers and risks